LFSC ETF Price & Analysis
LFSC ETF Chart & Stats
$34.99
--
Market closed
$34.99
--
Day’s Range― - ―
52-Week Range$18.78 - $40.10
Previous Close$34.99
VolumeN/A
Average Volume (3M)6.11K
AUM88.26M
NAV32.94
Expense Ratio0.54%
Holdings Count41
Beta1.10
Inception DateOct 30, 2024
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume3,575
30 Day Avg. Volume6,106
AlphaN/A
ETF Overview
F/M Emerald Life Sciences Innovation ETF
The F/M Emerald Life Sciences Innovation ETF (ticker: LFSC) is a dynamic investment vehicle tailored for those seeking exposure to cutting-edge advancements within the health care sector. This ETF is specifically concentrated on the Pharma, Biotech & Life Sciences niche, offering investors a unique opportunity to capitalize on the rapid innovation and growth potential in these fields. LFSC targets companies at the forefront of pharmaceutical development, biotechnology breakthroughs, and life sciences research, encompassing a broad spectrum of pioneering firms that are driving transformative changes in health care. With a focus on delivering strategic access to this vital segment, the F/M Emerald Life Sciences Innovation ETF is ideal for investors looking to diversify their portfolio with high-impact, future-focused investments that have the potential to redefine the health care landscape.
F/M Emerald Life Sciences Innovation ETF (LFSC) Fund Flow Chart
F/M Emerald Life Sciences Innovation ETF (LFSC) 1 year Net Flows: $15M
LFSC ETF News
LFSC ETF FAQ
What was LFSC’s price range in the past 12 months?
LFSC lowest ETF price was $18.78 and its highest was $40.10 in the past 12 months.
What is the AUM of LFSC?
As of Mar 30, 2026 The AUM of LFSC is 88.26M.
Is LFSC overvalued?
According to Wall Street analysts LFSC’s price is currently Undervalued.
Does LFSC pay dividends?
LFSC does not currently pay dividends.
How many shares outstanding does LFSC have?
Currently, no data Available
Which hedge fund is a major shareholder of LFSC?
Currently, no hedge funds are holding shares in LFSC
LFSC ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Cogent Biosciences, Inc.
9.21%
LivaNova PLC
7.12%
Spyre Therapeutics, Inc
5.22%
Mirum Pharmaceuticals
5.00%
United Therapeutics Corp.
4.93%
KalVista Pharmaceuticals, Inc.
4.75%
Travere Therapeutics, Inc.
4.65%
Guardant Health
4.35%
Bridgebio Pharma
4.12%
Nektar Therapeutics
3.99%
Total53.35%
See All Holdings